CNBC's Final Trades: Fiserv, ResMed, Monster Beverage And This Semiconductor Company

On CNBC’s “Halftime Report Final Trades,” Jenny Harrington of Gilman Hill Asset Management said Fiserv Inc FISV belongs to its growth portfolio.

The stock is trading at 16 times earnings and has the potential for 15% earnings growth ahead, Harrington said. The stock is “wildly oversold,” she added.

Another trader in the show named Qualcomm, Inc. QCOM, saying that its upcoming analyst day should be a catalyst.

Joseph Terranova of Virtus Investment Partners cited ResMed Inc. RMD as a top pick, noting the positives as being a San Diego-based medical equipment company with a focus on sleep disorder.

Pete Najarian named Monster Beverage Corp MNST. “I see some call buying in there and I think this stock’s going higher,” he commented.